TC
The Chair
Chair
–
Thomas R. Pieber
Chairman of the Division of Endocrinology and Metabolism
–
Dr Andrew John Mcglashan Richards
Non-Executive Chair and Chair of the Nomination Committee
5 yrs 6 mosAge: 66British
Simon John Ormiston
Non-Executive Director and Chair of the Audit & Risk Committee
1 yrs 1 mosAge: 53British
CE
Chief Executive Officer
CEO
–
CF
Chief Financial Officer
CFO
–
Mohammad Sohail Fazeli
Non-Executive Director
5 yrs 6 mosAge: 62British
WS
Wendy S. Lane
Clinical Endocrinologist
–
Jennifer C. Smith-Parker
Director of Insights
–
Eda Cengiz
Professor of Pediatrics
–
David Brayden
Full Professor of Advanced Drug Delivery
–
Randy Mrsny
Professor of Drug Delivery
–
Christopher Porter
Director of the Monash Institute of Pharmaceutical Sciences (MIPS)
–
Bruce Buckingham
Professor of Paediatrics (Endocrinology)
–
| Name | Role |
|---|---|
TC The Chair | Chair |
| Chairman of the Division of Endocrinology and Metabolism |
| Non-Executive Chair and Chair of the Nomination Committee |
| Non-Executive Director and Chair of the Remuneration Committee | |
| Non-Executive Director and Chair of the Audit & Risk Committee |
CE Chief Executive Officer | CEO |
| CEO | |
CF Chief Financial Officer | CFO |
| Chief Financial Officer and Executive Director | |
| Chief Scientific Officer | |
| Chief Development Officer | |
| Non-Executive Director |
WS Wendy S. Lane | Clinical Endocrinologist |
| Director of Insights |
| Professor of Pediatrics |
| Full Professor of Advanced Drug Delivery |
| Professor of Drug Delivery |
| Director of the Monash Institute of Pharmaceutical Sciences (MIPS) |
| Professor of Paediatrics (Endocrinology) |
| Director |